The Effects of COVID-19 on Patient Experience and Price Transparency
Ogi Kwon, of R1 Revenue Cycle Management (RCM) offers insights on lessons learned from the COVID-19 pandemic and the future of price transparency.
The COVID-19 pandemic provides an opportunity for organizations to think about how they can be proactive and monitor new regulatory changes in real time, said Ogi Kwon, a manager in the regulatory team at R1 RCM's advisory and assurance department.
In this interview with Chief Healthcare Executive™, Kwon explains how he feels price transparency as a whole while be something that continues to be iterated upon going forward and how requirements could take different forms.
R1 RCM is a revenue cycle management company that offers technology-driven solutions to transform health care providers' patient experience and financial performance.
As hospitals face cost pressures, concerns emerge over cuts in infection control
June 5th 2025The Association for Professionals in Infection Control and Epidemiology is hearing reports of layoffs in those programs. Leaders of the association and the Leapfrog Group warn about risks to patients.
